Seer
Seer Inc. is a biotechnology company specializing in proteomics research and analysis. They offer advanced tools and services, including the Proteograph Product Suite and Analysis Suite, aimed at enhancing scientific research in the life sciences. Their customers include researchers and organizations in the biotechnology sector seeking to gain deeper insights into biological processes through innovative proteomics solutions.
Headcount
Website visitors
Workforce
Headcount by location
- United States100%
Split by department
- Engineering & R&D49%
- Sales14%
- Operations8.7%
- Finance & Administration5.8%
- Other23%
Seniority distribution
- Less than 5 years63%
- 5 to 10 years31%
- 10 to 20 years5.3%
- 30 years and more1.1%
Funding
Raised to date
- 19 Apr 2026Company AcquisitionUndisclosed—
- 4 Dec 2020Ipo$175.0M—
6 earlier rounds, with their terms and sources.
Investors
T. Rowe PriceT. Rowe Price is an investment management firm that provides a range of financial services including mutual funds, ETFs, and separately managed accounts. The company serves individual investors, financial advisors, and institutional clients, helping324United States
InvusInvus is an investment management firm that empowers entrepreneurs by providing capital and strategic advisory services. With over $10 billion under management, Invus partners with businesses to help them innovate and transform their industries227United States
Aju Ib InvestmentAJU IB INVESTMENT is an investment firm specializing in venture capital and private equity. The company provides multi-stage investment solutions to innovative businesses, helping them secure funding and strategic guidance for growth. Their146South Korea
Wing Venture CapitalWing Venture Capital is a venture capital firm that specializes in early-stage investments and company building. They focus on supporting founders in the technology sector, particularly those innovating in AI and data. Wing provides resources142United States
Portfolio
Countries
- United States100%
Deal stage
- Series D100%
Deal size
- 10-50100%
Company size
- 11-50100%
Revenue
EBITDA
Revenue source: Public reported FY2025 (Stock exchange)
Recent news
- Seer CFO David Horn resigns, charles Endweiss takes over.
- Seer names Charles Endweiss as CFO.
8 more articles, with their sources and categories.
Deal terms
What each deal was actually worth — valuation, revenue and EBITDA multiples, and the filings behind them
Portfolio companies
Every holding by name, with what was paid, when, and how each one has grown since
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full Seer profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.